{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:29:07Z","timestamp":1793946547449,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013428","name":"Stichting Spieren voor Spieren","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eclinm.2026.104008","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:57:35Z","timestamp":1782856655000},"page":"104008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9350-2361","authenticated-orcid":false,"given":"Lina M.","family":"Vermeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6171-272X","authenticated-orcid":false,"given":"Fay-Lynn","family":"Asselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7132-5967","authenticated-orcid":false,"given":"Ruben P.A.","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-4644","authenticated-orcid":false,"given":"Inge","family":"Cuppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-7092","authenticated-orcid":false,"given":"Danny R.","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bea M.H.E.A.","family":"Visser\u2013de Heus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia M.J.","family":"Hogervorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs J.","family":"Ruyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5801-6692","authenticated-orcid":false,"given":"Bart","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0339-5506","authenticated-orcid":false,"given":"Renske I.","family":"Wadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8970-2740","authenticated-orcid":false,"given":"W. Ludo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2026.104008_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.eclinm.2026.104008_bib2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.eclinm.2026.104008_bib3","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/WNL.0b013e3182749eca","article-title":"Dysfunction of the neuromuscular junction in spinal muscular atrophy types 2 and 3","volume":"79","author":"Wadman","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2026.104008_bib4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/brain\/awab411","article-title":"Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy","volume":"145","author":"Habets","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.eclinm.2026.104008_bib5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/ene.13534","article-title":"Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4","volume":"25","author":"Wadman","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13023-018-0904-5","article-title":"A continuous repetitive task to detect fatigability in spinal muscular atrophy","volume":"13","author":"Stam","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.eclinm.2026.104008_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.eclinm.2026.104008_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.eclinm.2026.104008_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(21)00367-7","article-title":"Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"21","author":"Mercuri","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S1474-4422(22)00339-8","article-title":"Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial","volume":"21","author":"Masson","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJMoa2410120","article-title":"Risdiplam in presymptomatic spinal muscular atrophy","volume":"393","author":"Finkel","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2026.104008_bib12","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1111\/ene.15542","article-title":"Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy","volume":"29","author":"V\u00e1zquez-Costa","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib13","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.nmd.2022.07.083","article-title":"P.47 adaptive test for neuromuscular disorders: design of a wheelchair-based assessment","volume":"32","author":"Duong","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib14","series-title":"Overzicht van goedgekeurde compassionate use programma\u2019s","year":"2019"},{"key":"10.1016\/j.eclinm.2026.104008_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(94)00075-K","article-title":"Chaos in the classification of SMA: a possible resolution","volume":"5","author":"Dubowitz","year":"1995","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","article-title":"Childhood spinal muscular atrophy: controversies and challenges","volume":"11","author":"Mercuri","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib19","series-title":"Evrisdy: EPAR - product information","year":"2021"},{"key":"10.1016\/j.eclinm.2026.104008_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/mus.25430","article-title":"Revised upper limb module for spinal muscular atrophy: development of a new module","volume":"55","author":"Mazzone","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.eclinm.2026.104008_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2024.07.069","article-title":"218P inter-rater reliability of adapted test of neuromuscular disorders (ATEND) wheelchair-based assessment","volume":"43","author":"Nelson","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib22","doi-asserted-by":"crossref","first-page":"104441","DOI":"10.1016\/j.nmd.2024.07.454","article-title":"194P Longitudinal assessment of the adapted test for neuromuscular disease (ATEND) in individuals living with spinal muscular atrophy (SMA)","volume":"43","author":"Duong","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2021.10.009","article-title":"Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes","volume":"32","author":"Coratti","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib24","doi-asserted-by":"crossref","first-page":"e2103","DOI":"10.1212\/WNL.0000000000207878","article-title":"Systematic literature review of the natural history of spinal muscular atrophy: motor function, scoliosis, and contractures","volume":"101","author":"Aponte Ribero","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2026.104008_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11136-006-9109-9","article-title":"Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach","volume":"16","author":"de Vet","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eclinm.2026.104008_bib26","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1007\/s00586-024-08369-5","article-title":"Calculation of the minimum clinically important difference (MCID) using different methodologies: case study and practical guide","volume":"33","author":"Klukowska","year":"2024","journal-title":"Eur Spine J"},{"key":"10.1016\/j.eclinm.2026.104008_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.27384","article-title":"Different trajectories in upper limb and gross motor function in spinal muscular atrophy","volume":"64","author":"Coratti","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.eclinm.2026.104008_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac269","article-title":"Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study","volume":"4","author":"Scheijmans","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.eclinm.2026.104008_bib29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"Kaufmann","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2026.104008_bib30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib31","doi-asserted-by":"crossref","first-page":"e1988","DOI":"10.1212\/WNL.0000000000010540","article-title":"Muscle strength and motor function in adolescents and adults with spinal muscular atrophy","volume":"95","author":"Wijngaarde","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2026.104008_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","article-title":"Disease impact on general well-being and therapeutic expectations of European type II and type III spinal muscular atrophy patients","volume":"27","author":"Rouault","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-37462-6","article-title":"A real-world, multicentre, epidemiological study in Czech and Slovak adults with spinal muscular atrophy treated with risdiplam","volume":"16","author":"Parmova","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2026.104008_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp-2020-325022","article-title":"Motor unit gains in treated spinal muscular atrophy patients","volume":"92","author":"Sumner","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104008_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp-2020-324254","article-title":"Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen","volume":"92","author":"Kariyawasam","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.eclinm.2026.104008_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27755","article-title":"Risdiplam for the treatment of adults with spinal muscular atrophy: experience of the Northern Ireland neuromuscular service","volume":"67","author":"McCluskey","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.eclinm.2026.104008_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JND-230197","article-title":"Risdiplam real world data - looking beyond motor neurons and motor function measures","volume":"11","author":"Sitas","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.eclinm.2026.104008_bib38","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00415-024-12203-9","article-title":"Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment","volume":"271","author":"Brakemeier","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.eclinm.2026.104008_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.105397","article-title":"Two-year Risdiplam treatment in adults with spinal muscular atrophy: improvements in motor and respiratory function, quality of life and fatigue","volume":"52","author":"Iterbeke","year":"2025","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2026.104008_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103536","article-title":"Efficacy and safety of risdiplam in adults with 5q-associated spinal muscular atrophy: a nationwide observational cohort study in Austria","volume":"88","author":"Keritam","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.eclinm.2026.104008_bib41","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3390\/jcm13123418","article-title":"Patients\u2019 perceptions of nusinersen effects according to their responder status","volume":"13","author":"Lilien","year":"2024","journal-title":"J Clin Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:46:54Z","timestamp":1793944014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S2589537026002579"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104008","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104008"}}